Compare BAC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAC | MRK |
|---|---|---|
| Founded | 1784 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.0B | 260.2B |
| IPO Year | N/A | N/A |
| Metric | BAC | MRK |
|---|---|---|
| Price | $55.15 | $100.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 15 |
| Target Price | $55.81 | ★ $109.13 |
| AVG Volume (30 Days) | ★ 37.5M | 15.8M |
| Earning Date | 01-15-2026 | 10-30-2025 |
| Dividend Yield | 2.03% | ★ 3.39% |
| EPS Growth | 33.34 | ★ 58.08 |
| EPS | 3.66 | ★ 7.56 |
| Revenue | ★ $101,445,000,000.00 | $64,235,000,000.00 |
| Revenue This Year | $15.65 | $1.97 |
| Revenue Next Year | $6.19 | $4.96 |
| P/E Ratio | $15.06 | ★ $13.27 |
| Revenue Growth | ★ 7.21 | 1.68 |
| 52 Week Low | $33.07 | $73.31 |
| 52 Week High | $55.30 | $105.84 |
| Indicator | BAC | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 65.50 | 59.78 |
| Support Level | $53.27 | $96.06 |
| Resistance Level | $54.83 | $99.85 |
| Average True Range (ATR) | 0.89 | 2.46 |
| MACD | 0.16 | -0.70 |
| Stochastic Oscillator | 96.28 | 43.03 |
Bank of America is one of the largest financial institutions in the United States, with more than $3.2 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).